Convalescent Plasma for COVID-19: A Single Center Prospective Experience with Serial Antibody Measurements and Review of the Literature

Background: High-titer convalescent plasma given early for COVID-19 may decrease progression into a severe infection. Here, we reported a study of serial antibody measurements in patients who received CP at our center and performed a systematic review of randomized trials on CP. Methods: Our center...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Sonia N. Whang, Vivek D. Shah, Lu Pu, Parthiv Sheth, Gina N. Lucas, Joanne Lee, Michael Lee, Curtis Lacy, Penelope J. Duerksen-Hughes, Valeri Filippov, David J. H. Lee, Jennifer Veltman, Kanwaljeet Maken, Mark E. Reeves, Wesley Tait Stevens, Paul Herrmann, Huynh Cao, Eric Lau
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2022-08-01
סדרה:	Pathogens
נושאים:	convalescent plasma COVID-19 antibody biomarkers kinetics passive immunity
גישה מקוונת:	https://www.mdpi.com/2076-0817/11/9/958
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!